SequelSEC

NATURES SUNSHINE PRODUCTS INC NATR

Pharmaceutical Preparations · CIK 0000275053 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$492.02M
Fiscal year ended 2026-06-30
Operating income
$29.32M
Fiscal year ended 2026-06-30
Free cash flow
$18.08M
Fiscal year ended 2026-06-30

NATURES SUNSHINE PRODUCTS INC (NATR) reported revenue of $492.02M and net income of $18.10M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from NATURES SUNSHINE PRODUCTS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

NATURES SUNSHINE PRODUCTS INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$492.02M
Cost of revenue$132.04M
Gross profit$359.98M
Operating income$29.32M
Net income$18.10M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$28.68M
Income tax expense$9.98M
Diluted EPSUnavailable
Selling, general & administrative$182.56M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

NATURES SUNSHINE PRODUCTS INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$82.50M
Total assets$259.82M
Current assets$178.40M
Total liabilities$90.51M
Current liabilities$68.74M
Total equity incl. NCI$169.32M
Temporary (mezzanine) equityUnavailable
Inventory$71.73M
Accounts receivable$13.86M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$7.73M

Cash flow

NATURES SUNSHINE PRODUCTS INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$27.36M
Capital expenditures$9.28M
Investing cash flow-$9.28M
Financing cash flow-$15.96M
Net change in cash$1.16M
Stock-based compensation$6.47M
Common dividends paidUnavailable
Common share repurchases$6.52M
Depreciation & amortization$13.37M

Derived

NATURES SUNSHINE PRODUCTS INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$18.08M
Gross margin73.2%
Operating margin6.0%
FCF margin3.7%
SBC / revenue1.3%
Current ratio2.60x
Revenue YoY growth6.8%
Net margin3.7%
R&D / revenueUnavailable
CapEx / revenue1.9%
Long-term debt / equityUnavailable
Effective tax rate34.8%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NATR in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-10View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-05-06View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.